insights_auto
Why is EVT up 3.30%?
Dive Deeperchevron_right
EVT:FRA
Evotec SE
€ 2.88
arrow_upward
+3.30%(+0.092) 1D
10-р сарын 21, 22:00:00 (GMT+2) · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVT...
Open
€ 2.74
High
€ 2.88
Low
€ 2.72
Mkt. cap
498.74 сая
Avg. vol.
5.63 мян
Volume
7.00 мян
52-wk high
€ 7.49
52-wk low
€ 2.45
EPS
-€ 1.11
Shares outstanding
148.72 сая
No. of employees
4 мян
Open
€ 2.74
High
€ 2.88
Low
€ 2.72
Mkt. cap
498.74 сая
Avg. vol.
5.63 мян
Volume
7.00 мян
52-wk high
€ 7.49
52-wk low
€ 2.45
EPS
-€ 1.11
Shares outstanding
148.72 сая
No. of employees
4 мян
News stories
From web sources and news partners
AD HOC NEWS
·
4 цагийн өмнө
Evotec stock: RBC keeps EUR 10.00 target for Evotec stock
AD HOC NEWS
·
11 цагийн өмнө
Evotec appoints Joanna Holbrook as chief scientific officer. Evotec stock gains 1.47 percent
AD HOC NEWS
·
14 цагийн өмнө
Evotec stock at EUR 2.77 ahead of the Xetra open: drug group rises 1.84 percent
AD HOC NEWS
·
15 цагийн өмнө
Evotec's Earnings Beat Is Real — the Profit Is Not
Profile
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
About Evotec SE